Pulse Biosciences Shares nPulse™ Cardiac Catheter Data
Procedural success was achieved in 100% of evaluable patients at 6 months and 96% in 12 months Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the...
Category : Clinical Research, Pharma & Healthcare Financing
Pfizer Launches TrumpRx Program to Cut Drug Costs
Pfizer Inc. (NYSE: PFE) today announced the launch of its program on TrumpRx, making innovative medicines more affordable and accessible to millions of Americans. Starting today,...
Oncolytic Virus Trials Accelerate as 100+ Companies Advance Research
The oncolytic virus therapy landscape has expanded steadily over the past decade, with over 100 companies worldwide pursuing clinical or preclinical programs. A few leaders,...
China Approves Promega MSI Kit as KEYTRUDA® Companion Test
The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro diagnostic medical device in China....
WuXi Biologics, Vertex Sign License for T-cell Engager
WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has signed a license and research service...
Vetter Pharma to Build New Manufacturing Site in Germany
Strategic Investments in the EU and US strengthen Vetter’s Global Footprint Vetter, one of the world’s leading pharmaceutical service providers for the production of injectable...
PranaX Closes $17M Oversubscribed Series A Round
PranaX Corporation, a leading biotechnology company focused on regenerative biologics, today announced the closing of its oversubscribed $17 million Series A financing. The Series A...
Novaliq Gets FDA IND Clearance for NOV05 Uveitis Trial
Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on its unique water-free EyeSol® drug category, today announced that the U.S. Food...
Tenpoint Raises $235M to Launch YUVEZZI™ for Presbyopia
U.S. FDA Approves YUVEZZI™ as the only dual-agent, once daily presbyopia-correcting eye drop Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking...
Preclinical Data Supports TPC-026 for Chronic Metabolic Disorders
TETRAPHARM, a Copenhagen-based biopharmaceutical company focused on neuroscience, psychiatry, and metabolic disorders, today announced promising preclinical data for TPC-026, a novel investigational compound being developed for...
EU Approves Guerbet Elucirem™ Half-Dose for Children from Birth
Guerbet (FR0000032526 GBT), a global specialist in contrast media and solutions for medical imaging, is delighted to announce the approval by European Commission of a...
Bayer to Present Phase III OCEANIC-STROKE Results
Bayer today announced that the main results from its global, landmark Phase III study OCEANIC-STROKE of asundexian in secondary stroke prevention, will be presented during...
Adenia Partners Makes First Majority Investment in Egypt
Adenia Partners (“Adenia”), a leading private equity firm focused on growth opportunities in Africa, has signed definitive agreements to acquire a majority stake in Parkville...
J. Craig Venter Launches Diploid Genomics, Advancing Human Genomics
Healthier Capital, a leading health-tech venture capital firm, joins as a co-founder and sole external investor in seed round Diploid Genomics, Inc. (DGI), an AI-driven...
Azafaros to Present Nizubaglustat Research at WORLDSymposium 2026
Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced that its...